ArticleAntimicrobial agents and chemotherapy2022

Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131.

Minh-Duy Phan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.